Tatsumi Mitsuaki, Engles James M, Ishimori Takayoshi, Nicely O'Bod, Cohade Christian, Wahl Richard L
Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
J Nucl Med. 2004 Jul;45(7):1189-93.
Physiologic (18)F-FDG uptake in areas of supraclavicular fat in humans ("USA-Fat") has recently been recognized as (18)F-FDG uptake in apparent brown adipose tissue (BAT) using fused PET/CT technology. In this study, we evaluated (18)F-FDG uptake in BAT of rats to determine whether pharmacologic or physiologic interventions affect the uptake, knowing that BAT has a high density of adrenergic innervation.
Seven- to 8-wk-old female Lewis rats receiving intravenous (18)F-FDG injections were examined under various conditions to evaluate (18)F-FDG biodistribution into interscapular BAT and major organs. In series 1, rats were given ketamine-based anesthesia or were exposed to cold (4 degrees C for 4 h) to determine whether these interventions increased (18)F-FDG uptake in BAT. In series 2, anesthetized rats (ketamine-based anesthesia) were given propranolol, reserpine, or diazepam intraperitoneally before (18)F-FDG injection to determine whether the drug reduced (18)F-FDG uptake in BAT. The control and treated groups in series 2 were also evaluated with (18)F-FDG PET/CT imaging.
In series 1, anesthesia or exposure to cold increased (18)F-FDG uptake in BAT to levels 14-fold and 4.9-fold, respectively, greater than the control nonstimulated values. BAT uptake was high, comparable to that in the brain. In series 2, (18)F-FDG uptake in BAT was significantly decreased to less than 30% of the control level after propranolol or reserpine (P < 0.05). Diazepam did not significantly decrease (18)F-FDG uptake in BAT. (18)F-FDG PET/CT findings reflected these biodistribution data: The control and diazepam groups exhibited intense (18)F-FDG uptake in BAT, whereas the propranolol and reserpine groups showed only faint to mild (18)F-FDG uptake in BAT. Among several organs whose (18)F-FDG uptake was affected after predosing drugs, the heart exhibited considerable decreases in tracer uptake with propranolol or reserpine.
This rodent study demonstrated that BAT can exhibit high (18)F-FDG uptake under stimulated conditions including exposure to cold and that propranolol or reserpine treatment can remarkably reduce the high (18)F-FDG uptake in BAT. The effect of these drugs on (18)F-FDG uptake in human BAT, as well as on tracer accumulation in other organs, should carefully be evaluated clinically to minimize the USA-Fat artifact.
人体锁骨上脂肪区域(“美国脂肪”)的生理性(18)F-FDG摄取最近被认为是使用PET/CT融合技术在明显的棕色脂肪组织(BAT)中的(18)F-FDG摄取。在本研究中,我们评估了大鼠BAT中的(18)F-FDG摄取,以确定药物或生理干预是否会影响摄取,因为已知BAT具有高密度的肾上腺素能神经支配。
对接受静脉注射(18)F-FDG的7至8周龄雌性Lewis大鼠在各种条件下进行检查,以评估(18)F-FDG在肩胛间BAT和主要器官中的生物分布。在系列1中,给予大鼠氯胺酮麻醉或使其暴露于寒冷环境(4℃4小时),以确定这些干预措施是否会增加BAT中的(18)F-FDG摄取。在系列2中